To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient

Gastritis Chronic Clinical Trial

Official title:
A Multi-center, Double-blind, Randomized, Parallel, Active-controlled, Non-inferiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW1903 in Patients With Gastritis

Status Completed

Clinical Trial Summary

A Multi-center, Double-blind, Randomized, Parallel, Active-controlled, Non-inferiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW1903 in Patients with Gastritis

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05163756
Study type	Interventional
Source	Daewon Pharmaceutical Co., Ltd.
Contact
Status	Completed
Phase	Phase 3
Start date	November 25, 2020
Completion date	May 10, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03443804` - To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients	Phase 3
Active, not recruiting	`NCT04702542` - To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.	N/A
Recruiting	`NCT06151210` - Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis	Phase 3
Completed	`NCT06269380` - Evaluation of Antral Biopsies Obtained in Normal Esophagogastroduodenoscopy	N/A